Executive Summary
An overseas medical-device company should classify the product, identify the responsible applicant or filing entity, confirm whether registration or filing applies, prepare the required Chinese-language materials and appoint a domestic enterprise legal person where the official rules require an agent for an overseas applicant. The NMPA provisions distinguish imported Class I filing from imported Class II and Class III registration and require evidence about safety, effectiveness, quality and, in relevant cases, overseas marketing status. The exact route depends on product classification, intended use, technical characteristics and the current regulatory catalogue.
Why Classification Comes First
The official NMPA provisions state that Class I devices are subject to filing while Class II and Class III devices are subject to registration, with imported Class I filing and imported Class II and Class III review handled by NMPA under the stated framework. Classification therefore determines the authority, evidence and review route.
Core Registration Questions
| Question | Why it matters | Evidence to prepare |
|---|---|---|
| Product classification | Determines filing or registration route | Classification basis and catalogue check |
| Applicant responsibility | Shows who carries legal responsibility | Applicant, filer or domestic agent information |
| Technical evidence | Supports safety, effectiveness and quality | Product technical requirements, testing and clinical evaluation where required |
| Language | Controls dossier usability | Chinese application documents and original foreign documents |
| Overseas status | May be required for imported devices | Marketing certificate or qualifying explanation |
| Quality system | Supports lifecycle control | Quality-management evidence and change controls |
Step-by-Step Process
- Define intended use, product function, model and manufacturing site.
- Check the classification rules and applicable catalogue.
- Confirm whether the route is filing or registration and identify the authority.
- Appoint the domestic enterprise legal person where the overseas applicant route requires it.
- Prepare Chinese application documents and retain original foreign-language materials.
- Prepare technical, testing, clinical and quality evidence required by the route.
- Check imported-device marketing-certificate requirements and exceptions.
- Plan lifecycle changes, renewal, post-market monitoring and record retention.
What the Official Rules Say About Overseas Applicants
The NMPA provisions state that an overseas applicant or filing entity shall designate a domestic enterprise legal person to act as its agent and assist with the relevant obligations. They also state that registration documents should be in Chinese, with original foreign-language documents provided at the same time when translated, and that imported-device applications may require a marketing certificate from the competent authority of the country or region where the applicant or manufacturing site is registered.
Common Mistakes
- Choosing a class based only on the product name.
- Treating a distributor as the regulatory agent without checking responsibility.
- Submitting translated documents without retaining originals.
- Ignoring technical changes to the registered product or manufacturing site.
- Assuming overseas approval always replaces China registration.
- Budgeting only the filing fee and ignoring testing, translation, agent and evidence work.
Limitations
This guide cannot determine the classification or approval route for a specific device. The company must provide the actual intended use, structure, materials, software, manufacturing site and evidence to NMPA or a qualified regulatory specialist.
Conclusion
The reliable sequence is classification, route, responsible entity, Chinese dossier, technical evidence and lifecycle controls. Start with the official NMPA rules and confirm the product-specific path before commercial launch.
Sources and Review Date
- NMPA, Provisions for Medical Device Registration and Filing – classification, filing, registration, agent and dossier requirements
- NMPA Medical Devices official section – official notices and current medical-device materials
Last reviewed: 2026-07-14
